Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00630669 · ClinicalTrials.gov registry record · NA

Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT00630669: Completed NA study, sponsored by University of California, Los Angeles.

NCT00630669 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00630669, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

The purpose of this study is to determine which treatment, band ligation (placing rubber bands around the hemorrhoids) or BICAP electrocoagulation (using electricity to cauterize) is safer and more effective endoscopic treatment for bleeding internal hemorrhoids.

Interventions

  • PROCEDURE Rubber band ligation
  • PROCEDURE Bipolar coagulation

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 1997-12
Est. Completion 2001-05
Phase NA

What the finished NCT00630669 record still lists

NCT00630669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Rubber band ligation is the first listed.

NCT00630669 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00630669 about?

NCT00630669 is a clinical study titled "Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe". The purpose of this study is to determine which treatment, band ligation (placing rubber bands around the hemorrhoids) or BICAP electrocoagulation (using electricity to cauterize) is safer and more effective endoscopic treatment for bleeding internal hemorrhoids.

What is the current status of trial NCT00630669?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 1997-12. Estimated completion is 2001-05.

What interventions are being tested in trial NCT00630669?

The interventions under investigation include: Rubber band ligation (PROCEDURE), Bipolar coagulation (PROCEDURE).

Who is sponsoring clinical trial NCT00630669?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00630669's enrollment target sits among peer trials

45 1411th of 2000 higher than 578 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00630669, the US trial registry maintained by the National Library of Medicine. NCT00630669 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.